• BTK Inhibitors in Multiple Sclerosis Treatment

  • Apr 21 2025
  • Duración: 21 m
  • Podcast

BTK Inhibitors in Multiple Sclerosis Treatment

  • Resumen

  • Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.

    Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.

    Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.

    Disclosures can be found at Neurology.org.

    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre BTK Inhibitors in Multiple Sclerosis Treatment

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.